J. Gabrielsson

发表

Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats

M. Jirstrand, J. Leander, J. Almquist, 2015, The AAPS Journal.

Dose-Response-Time Data Analysis: An Underexploited Trinity

M. Jirstrand, S. Hjorth, R. Andersson, 2018, Pharmacological Reviews.

Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols

M. Jirstrand, M. Cvijovic, C. Ekstrand, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.

S. Visser, L. Nilsson, J. Gabrielsson, 2007, Journal of pharmacological and toxicological methods.

Model‐Based Evaluation of Radiation and Radiosensitizing Agents in Oncology

Astrid Zimmermann, Mats Jirstrand, Johan Gabrielsson, 2017, CPT: pharmacometrics & systems pharmacology.

Does In Vitro Potency Predict Clinically Efficacious Concentrations?

S. Hjorth, J. Gabrielsson, R. Jansson-Löfmark, 2020, Clinical pharmacology and therapeutics.

Challenge model of TNFα turnover at varying LPS and drug provocations

M. Jirstrand, M. Cvijovic, E. Hoppe, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Kinetics of nicotine and its metabolites in animals

M. Gumbleton, J. Gabrielsson, 1993 .

Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.

M. Fink, J. Mochel, J. Riviere, 2016, Journal of veterinary pharmacology and therapeutics.

Constant-rate infusion of nicotine and cotinine. I. A physiological pharmacokinetic analysis of the cotinine disposition, and effects on clearance and distribution in the rat

J. Gabrielsson, Ulf Boniesson, 1987, Journal of Pharmacokinetics and Biopharmaceutics.

Phase I: The First Opportunity for Extrapolation from Animal Data to Human Exposure

S. Curry, M. Marler, D. McCarthy, 2002 .

Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.

Johan Gabrielsson, Martin Jørgensen, C. Bundgaard, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

PK/PD Modeling of CNS Drug Candidates

L. Peletier, S. Hjorth, J. Gabrielsson, 2015 .

Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats

L. Peletier, C. Ahlström, J. Gabrielsson, 2013, Journal of Pharmacokinetics and Pharmacodynamics.

Quantitative analysis of rate and extent of tolerance of biomarkers: application to nicotinic acid-induced changes in non-esterified fatty acids in rats.

L. Peletier, C. Ahlström, J. Gabrielsson, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evaluation and translation of combination therapies in oncology – A quantitative approach

M. Jirstrand, J. Almquist, J. Gabrielsson, 2018, European journal of pharmacology.

In vivo potency revisited – Keep the target in sight

L. Peletier, S. Hjorth, J. Gabrielsson, 2017, Pharmacology & therapeutics.

Modeling Drug- and System-Related Changes in Body Temperature: Application to Clomethiazole-Induced Hypothermia, Long-Lasting Tolerance Development, and Circadian Rhythm in Rats

L. Peletier, S. Visser, J. Gabrielsson, 2006, Journal of Pharmacology and Experimental Therapeutics.

Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions

L. Peletier, C. Ahlström, J. Gabrielsson, 2013, Journal of Pharmacokinetics and Pharmacodynamics.

Tissue uptake, distribution and elimination of (14)C-PFOA in zebrafish (Danio rerio).

A. Bergman, M. Sundström, J. Gabrielsson, 2015, Aquatic toxicology.

Eating a meal increases the clearance of ethanol given by intravenous infusion.

J. Gabrielsson, A. Jones, R. Hahn, 1994, Alcohol and alcoholism.

Non‐steady‐state kinetics of low density lipoproteins in man: studies after plasma exchange in healthy subjects and patients with familial hypercholesterolaemia

M. Eriksson, B. Angelin, L. Berglund, 1993, European journal of clinical investigation.

A Pharmacokinetic Model of Intravenously Administered Hyaluronan in Sheep

T. Laurent, J. Gabrielsson, B. Gerdin, 1989, Pharmaceutical Research.

PKPD awareness is vital if we are to attempt to relate preclinical results to the acute and long term consequences in humans

U. Bredberg, P. Gillberg, J. Gabrielsson, 2009 .

Tumor Static Concentration Curves in Combination Therapy

M. Jirstrand, J. Almquist, J. Gabrielsson, 2017, The AAPS Journal.

Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine

B. Olsson, J. Gabrielsson, P. Bolme, 2004, European Journal of Clinical Pharmacology.

Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents

M. Jirstrand, J. Almquist, J. Gabrielsson, 2019, Cancer Chemotherapy and Pharmacology.

Pharmacodynamic modelling of reversible gastric acid pump inhibition in dog and man.

M. Karlsson, J. Gabrielsson, U. Eriksson, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Dosing profile profoundly influences nicotinic acid’s ability to improve metabolic control in rats

N. Oakes, J. Gabrielsson, Tobias Kroon, 2015, Journal of Lipid Research.

Michaelis-Menten from an In Vivo Perspective: Open Versus Closed Systems

L. Peletier, J. Gabrielsson, 2018, The AAPS Journal.

Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S]

T. Baccega, N. Oakes, J. Gabrielsson, 2016, Journal of Lipid Research.

Modeling energy intake by adding homeostatic feedback and drug intervention

S. Hjorth, P. Gennemark, J. Gabrielsson, 2014, Journal of Pharmacokinetics and Pharmacodynamics.

The influence of drug input rate on the development of tolerance to frusemide.

H. Scheinin, G. Alván, J. Gabrielsson, 1998, British journal of clinical pharmacology.

Modeling and design of challenge tests: Inflammatory and metabolic biomarker study examples.

L. Peletier, S. Hjorth, R. Pehrson, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro

D. Richards, A. Hainsworth, A. Cross, 2001, Neuropharmacology.

Time course of enzyme induction in humans: Effect of pentobarbital on nortriptyline metabolism

E. Steiner, C. Bahr, J. Gabrielsson, 1998, Clinical pharmacology and therapeutics.

Integration of Pharmacokinetic and Pharmacodynamic Reasoning and Its Importance in Drug Discovery

S. Hjorth, J. Gabrielsson, 2018, Early Drug Development.

Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity.

P. Edlund, P. Höglund, N. Brynne, 1997, International journal of clinical pharmacology and therapeutics.

Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat.

S. Visser, S. Martinsson, J. Gabrielsson, 2005, European journal of pharmacology.

Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics.

J. Gabrielsson, L. Birgerson, I. Wallenbeck, 1996, Acta obstetricia et gynecologica Scandinavica. Supplement.

Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments

M. Jirstrand, R. Andersson, J. Almquist, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

Microsoft Word-58490786-file00

J. Gabrielsson, A. Green, 2009 .

Translational neuropharmacology and the appropriate and effective use of animal models

J. Gabrielsson, A. Green, K. Fone, 2011, British journal of pharmacology.

Challenging the dose‐response‐time data approach: Analysis of a complex system

M. Jirstrand, R. Andersson, J. Almquist, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Modeling of dose–response–time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles

W. Jusko, J. Gabrielsson, L. Alari, 2000, Biopharmaceutics & drug disposition.

New Equilibrium Models of Drug-Receptor Interactions Derived from Target-Mediated Drug Disposition

L. Peletier, J. Gabrielsson, 2018, The AAPS Journal.

Clinical pharmacokinetics of clozapine in chronic schizophrenic patients

U. Bondesson, Y. Cheng, L. Lindström, 2004, European Journal of Clinical Pharmacology.

Accumulation and turnover of metabolites of toluene and xylene in nasal mucosa and olfactory bulb in the mouse.

J. Gabrielsson, B. Danielsson, H. Ghantous, 1990, Pharmacology & toxicology.

A study of Mg/Ca in benthic foramini-fera sampled across a large salinity gradient

J. Gabrielsson, 2014 .

Constant rate of infusion--improvement of tests for teratogenicity and embryotoxicity.

L. Paalzow, J. Gabrielsson, S. Larsson, 1985, Life sciences.

Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration

Johan Gabrielsson, G. Alván, G. Paintaud, 1996, Clinical pharmacology and therapeutics.

Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications

Johan Gabrielsson, Daniel Weiner, D. Weiner, 2002 .

Joint Feedback Analysis Modeling of Nonesterified Fatty Acids in Obese Zucker Rats and Normal Sprague–Dawley Rats after Different Routes of Administration of Nicotinic Acid

L. Peletier, M. Jirstrand, J. Leander, 2014, Journal of pharmaceutical sciences.

Determination of potato glycoalkaloids and their aglycone in blood serum by high-performance liquid chromatography. Application to pharmacokinetic studies in humans.

K. Hellenäs, J. Gabrielsson, L. Lööf, 1992, Journal of chromatography.

A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.

H. Lithell, A. Lindberg, G. Tufveson, 1986, Transplantation proceedings.

Non-compartmental analysis.

Johan Gabrielsson, D. Weiner, J. Gabrielsson, 2012, Methods in molecular biology.

Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs.

S. Visser, L. Nilsson, J. Gabrielsson, 2006, Journal of pharmacological and toxicological methods.

Effects of dietary sodium selenite supplementation on salicylate-induced embryo- and fetotoxicity in the rat.

K. Hellenäs, J. Gabrielsson, E. Cekan, 1990, Toxicology.

Disposition of morphine-3-glucuronide in the pregnant rhesus monkey.

A. Rane, J. Gabrielsson, E. Gerdin, 1990, Pharmacology & toxicology.

Dynamics of target-mediated drug disposition.

L. Peletier, J. Gabrielsson, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Proposals for improving risk assessment in reproductive toxicology.

J. Gabrielsson, K. Larsson, 1990, Pharmacology & toxicology.

Volume Turnover Kinetics of Fluid Shifts after Hemorrhage, Fluid Infusion, and the Combination of Hemorrhage and Fluid Infusion in Sheep

D. Prough, C. Svensen, D. Traber, 2005, Anesthesiology.

Pharmacokinetics of i.v. and rectal methohexitone in children.

J. Gabrielsson, S. Björkman, M. Corbey, 1987, British journal of anaesthesia.

Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification

Johan Gabrielsson, Lambertus A. Peletier, L. Peletier, 2012, Journal of Pharmacokinetics and Pharmacodynamics.

Comprar Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, Fourth Edition | Johan Gabrielsson | 9789197651004 | Informa Healthcare

Johan Gabrielsson, D. Weiner, J. Gabrielsson, 2007 .

Do ethanol and deuterium oxide distribute into the same water space in healthy volunteers?

B. Sandhagen, J. Gabrielsson, A. Jones, 2001, Alcoholism, clinical and experimental research.

Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model

M. Karlsson, U. Bondesson, L. Paalzow, 1985, Journal of Pharmacokinetics and Biopharmaceutics.

Dose-response-time modelling: Second-generation turnover model with integral feedback control.

Robert Andersson, Neil D. Evans, Michael J. Chappell, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Dose-response-time data analysis involving nonlinear dynamics, feedback and delay.

L. Peletier, J. Gabrielsson, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A quantitative approach to analysing cortisol response in the horse.

M. Hedeland, U. Bondesson, C. Ekstrand, 2016, Journal of veterinary pharmacology and therapeutics.

Animal Health Modeling & Simulation Society: a new society promoting model-based approaches in veterinary pharmacology.

P. Toutain, R. Gehring, M. Fink, 2013, Journal of veterinary pharmacology and therapeutics.

MDMA: On the translation from rodent to human dosing

C. Marsden, K. Fone, J. Gabrielsson, 2009, Psychopharmacology.

A novel bone conduction implant (BCI): Engineering aspects and pre-clinical studies

Stefan Stenfelt, Sabine Reinfeldt, Bo Håkansson, 2010, International Journal of Audiology.

Role of Variability in Explaining Ethanol Pharmacokinetics

Robert G. Hahn, J. Gabrielsson, A. Jones, 2003, Clinical pharmacokinetics.

Concomitant single-dose and multiple-dose pharmacokinetics of terodiline in man, with a note on its enantiomers and major metabolites.

J. Gabrielsson, E. Larsson, A. Johansson, 1995, Pharmacology & toxicology.

Pharmacokinetics of R(+)-terodiline given intravenously and orally to healthy volunteers.

J. Gabrielsson, L. Palmér, B. Hallén, 1993, Pharmacology & toxicology.

Analysis of methadone disposition in the pregnant rat by means of a physiological flow model

U. Bondesson, L. Paalzow, J. Gabrielsson, 1985, Journal of Pharmacokinetics and Biopharmaceutics.

A turnover model of irreversible inhibition of gastric acid secretion by omeprazole in the dog.

M O Karlsson, M. Karlsson, J. Gabrielsson, 2000, The Journal of pharmacology and experimental therapeutics.

Feedback modeling of non-esterified fatty acids in rats after nicotinic acid infusions

Johan Gabrielsson, Lambertus A. Peletier, Rasmus Jansson-Löfmark, 2010, Journal of Pharmacokinetics and Pharmacodynamics.

Turnover Modeling of Non-Esterified Fatty Acids in Rats after Multiple Intravenous Infusions of Nicotinic Acid

L. Peletier, J. Gabrielsson, K. Wallenius, 2009, Dose-response : a publication of International Hormesis Society.

Pattern Recognition in Pharmacokinetic Data Analysis

Johan Gabrielsson, Bernd Meibohm, Daniel Weiner, 2015, The AAPS Journal.

New methods for probing the disposition of nicotine in humans

J. Wahren, J. Gabrielsson, M. Curvall, 1993 .

Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.

M. Eriksson, L. Nilsson, J. Gabrielsson, 2005, Journal of Pharmaceutical and Biomedical Analysis.

A Pharmacodynamic Turnover Model Capturing Asymmetric Circadian Baselines of Body Temperature, Heart Rate and Blood Pressure in Rats: Challenges in Terms of Tolerance and Animal-handling Effects

L. Peletier, S. Visser, J. Gabrielsson, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Exposure-response modeling improves selection of radiation and radiosensitizer combinations

M. Jirstrand, J. Almquist, J. Gabrielsson, 2021, Journal of Pharmacokinetics and Pharmacodynamics.

A study of Mg / Ca in benthic foraminifera sampled across a large salinity gradient Master thesis

J. Gabrielsson, 2015 .

A modeling approach for compounds affecting body composition

Johan Gabrielsson, Peter Gennemark, Rasmus Jansson-Löfmark, 2013, Journal of Pharmacokinetics and Pharmacodynamics.

An Integrative Approach for Improved Assessment of Cardiovascular Safety Data

M. Jirstrand, J. Gabrielsson, E. Martel, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Pharmacokinetic Steady-States Highlight Interesting Target-Mediated Disposition Properties

L. Peletier, J. Gabrielsson, 2017, The AAPS Journal.

Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations.

Hugues Dolgos, Johan Gabrielsson, Ulf Bredberg, 2009, Drug discovery today.

Challenge model of TNFα turnover at varying LPS and drug provocations

M. Jirstrand, M. Cvijovic, E. Hoppe, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of tolterodine

L. Bertilsson, N. Brynne, J. Gabrielsson, 1998, Clinical pharmacology and therapeutics.

Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.

J. Gabrielsson, A. Jones, R. Hahn, 2000, British journal of clinical pharmacology.

A physiological pharmacokinetic model for morphine disposition in the pregnant rat

L. Paalzow, J. Gabrielsson, 1983, Journal of Pharmacokinetics and Biopharmaceutics.

Impact of mathematical pharmacology on practice and theory: four case studies

Johan Gabrielsson, Lambertus A. Peletier, L. Peletier, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

Plasma concentration-dependent suppression of endogenous hydrocortisone in the horse after intramuscular administration of dexamethasone-21-isonicotinate.

M. Hedeland, U. Bondesson, C. Ekstrand, 2015, Journal of veterinary pharmacology and therapeutics.

A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.

Stig Johan Wiklund, Johan Gabrielsson, Sandra A G Visser, 2007, Journal of pharmacological and toxicological methods.

The pharmacokinetics of cyclosporine A in uremic patients.

A. Lindberg, G. Tufveson, J. Gabrielsson, 1986, Transplantation proceedings.

Optimising in vivo pharmacology studies--Practical PKPD considerations.

Johan Gabrielsson, A Richard Green, Piet H Van der Graaf, 2010, Journal of pharmacological and toxicological methods.

Quantitative Pharmacology or Pharmacokinetic Pharmacodynamic Integration Should Be a Vital Component in Integrative Pharmacology

J. Gabrielsson, A. R. Green, J. Gabrielsson, 2009, Journal of Pharmacology and Experimental Therapeutics.

Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development.

Johan Gabrielsson, P. H. van der Graaf, J. Gabrielsson, 2009, Future medicinal chemistry.

A Flexible Nonlinear Feedback System That Captures Diverse Patterns of Adaptation and Rebound

Johan Gabrielsson, Lambertus A. Peletier, L. Peletier, 2008, The AAPS Journal.

A nonlinear feedback model capturing different patterns of tolerance and rebound.

L. Peletier, J. Gabrielsson, 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Modelling of oscillatory cortisol response in horses using a Bayesian population approach for evaluation of dexamethasone suppression test protocols

M. Jirstrand, M. Cvijovic, C. Ekstrand, 2019, Journal of Pharmacokinetics and Pharmacodynamics.

Pharmacokinetics of Quinacrine after Intrapleural Instillation in Rabbits and Man

J. Gabrielsson, S. Björkman, L. Elisson, 1989, The Journal of pharmacy and pharmacology.

Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions

L. Peletier, C. Ahlström, J. Gabrielsson, 2013, Journal of Pharmacokinetics and Pharmacodynamics.

Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats

M. Jirstrand, J. Leander, J. Almquist, 2015, The AAPS Journal.

Modeling energy intake by adding homeostatic feedback and drug intervention

S. Hjorth, P. Gennemark, J. Gabrielsson, 2015, Journal of Pharmacokinetics and Pharmacodynamics.

Mixed-effects modeling using stochastic differential equations - Applications to pharmacokinetic modeling

M. Jirstrand, J. Leander, J. Almquist, 2014 .

Challenges of a mechanistic feedback model describing nicotinic acid-induced changes in non-esterified fatty acids in rats

L. Peletier, C. Ahlström, J. Gabrielsson, 2013, Journal of Pharmacokinetics and Pharmacodynamics.

Dynamics of target-mediated drug disposition: how a drug reaches its target

J. Gabrielsson, L. A. Peletier, 2013, Computational Geosciences.

Impact of enzyme turnover on the dynamics of the Michaelis-Menten model.

L. Peletier, J. Gabrielsson, 2022, Mathematical biosciences.

Michaelis-Menten from an In Vivo Perspective: Open Versus Closed Systems

L. Peletier, J. Gabrielsson, 2018, The AAPS Journal.

Challenges in Pharmacology Modelling

L. Peletier, J. Gabrielsson, 2015 .

Challenges in Pharmacology Modelling

L. Peletier, J. Gabrielsson, 2014, Journal of Dynamics and Differential Equations.

Kinetics of circulating hyaluronan in humans

B. Gerdin, J. Gabrielsson, T. Laurent, 1994 .

Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance

S. Hjorth, J. Gabrielsson, 2023, Pharmacological Reviews.

Gastric Acid Secretion in the Dog: A Mechanism-Based Pharmacodynamic Model for Histamine Stimulation and Irreversible Inhibition by Omeprazole

M. Karlsson, J. Gabrielsson, U. Eriksson, 2002, Journal of Pharmacokinetics and Pharmacodynamics.

Pharmacodynamic-pharmacokinetic integration as a guide to medicinal chemistry.

Michael Rowley, Johan Ulander, Johan Gabrielsson, 2011, Current topics in medicinal chemistry.

Comparisons of basic Target-Mediated Drug Disposition (TMDD) and Ligand Facilitated Target Removal (LFTR).

L. Peletier, J. Gabrielsson, R. Jansson-Löfmark, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Lost in translation: What's in an EC50? Innovative PK/PD reasoning in the drug development context.

L. Peletier, S. Hjorth, J. Gabrielsson, 2018, European journal of pharmacology.

Modeling of dose–response–time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles

W. Jusko, J. Gabrielsson, Liisi Alari, 2000, Biopharmaceutics & drug disposition.

Methodology for pharmacokinetic/pharmacodynamic data analysis.

Weiner, Gabrielsson, D. Weiner, 1999, Pharmaceutical science & technology today.

Model-based assessment of combination therapies – ranking of radiosensitizing agents in oncology

M. Jirstrand, J. Gabrielsson, F. Lignet, 2023, BMC Cancer.

Mixture dynamics: dual action of inhibition and stimulation.

L. Peletier, J. Gabrielsson, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pattern Recognition in Pharmacodynamic Data Analysis

S. Hjorth, J. Gabrielsson, 2015, The AAPS Journal.

Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics

Kristoffer Andersson, Mats Jirstrand, Johan Gabrielsson, 2014, Comput. Methods Programs Biomed..

Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments

M. Jirstrand, R. Andersson, J. Almquist, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat

L. Paalzow, J. Gabrielsson, L. Nordström, 1984, Journal of Pharmacokinetics and Biopharmaceutics.

An extended physiological pharmacokinetic model of methadone disposition in the rat: Validation and sensitivity analysis

Torgny Groth, T. Groth, J. Gabrielsson, 1988, Journal of Pharmacokinetics and Biopharmaceutics.